Drug Type CAR-T |
Synonyms aCD19-TCRz-41BB, alphaCD19-TCRz-41BB, CD19-41BB-tEGFR |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |